Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013

CHARLESTON, WV – When medical marijuana becomes available in West Virginia in another 17-months, you won’t see it inedible or smokable plant forms like these. Creams, oils, and pills containing the substance are the only options. That disappoints cancer survivor Rusty Williams, who says medical pot got him through chemotherapy. “And within 30 seconds of
READ MORE
Researchers are exploring the potential of cannabidiol (CBD) as a treatment alternative for crack cocaine use disorder, according to a recent study highlighted by Forbes. The study found that CBD might offer significant benefits for individuals battling this challenging addiction, with fewer adverse effects compared to traditional pharmaceutical interventions. This development offers a glimmer of
READ MORE
Today marijuana is re-evaluated on legal and cultural levels after it is considered as an illegal substance to use. According to recent research conducted majority are supporting marijuana for recreational and medical use. As such, many countries have legalized marijuana for recreational purposes, medical purposes, and both as well. Still, some researchers and lawmakers would
READ MORE
COLUMBIA, S.C. — A seven-year fight to pass a medical marijuana bill may have abruptly ended Wednesday in South Carolina when a House leader ruled the proposal contains an unconstitutional tax increase and cannot be considered further. The decision shocked leaders in the state Senate and may have repercussions well beyond failing to make South
READ MORE
Studies have been taking place at research facilities, hospitals and Universities around the globe. While many of these studies have nothing but positive results others have been less promising. There have been plenty of cases for example where the use of cannabidiol does not help the patient in any visible way, some patients simply continue
READ MORE
In a landmark regulatory shift, President Donald Trump’s Department of Justice has rescinded dozens of pending and projected rules, dismantling longstanding DEA obstacles to medical cannabis research. The decisive move, announced September 15, strips away the procedural shields that allowed the DEA to delay legitimate marijuana science, notably for FDA-authorized clinical trials targeting Huntington’s disease
READ MORE